id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-4087-0001,FDA,FDA-2018-N-4087,The Food and Drug Administration’s Proposed Current Good Manufacturing Practice Policies for Outsourcing Facilities: Considerations Regarding Access to Office Stock; Public Meeting; Request for Comments,Notice,Request for Comments,2018-12-11T05:00:00Z,2018,12,2018-12-11T05:00:00Z,2019-06-22T03:59:59Z,2019-06-22T01:02:43Z,2018-26725,0,0,0900006483980af7